The present invention relates to methods of monitoring, via polymerase chain reaction, the clinical progression of human immunodeficiency virus infection and its response to antiretroviral therapy. According to the invention, polymerase chain reaction assays may be used to predict immunological decline and to identify, at an early stage, patients whose infection has become resistant to a particular antiretroviral drug regimen.

 
Web www.patentalert.com

< Method for producing human antibodies in SCID mice which uses dendritic cells pulsed with antigen-antibody complexes and antigen-antibody complexes as immunizing agents

< Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof

> Compositions and methods for detecting severe acute respiratory syndrome coronavirus

> Method of detecting equine glycogen storage disease IV
~ 00299